Skip to main content
Glama

Compare Entities

compare_entities
Read-onlyIdempotent

"Compare X and Y" / "X vs Y" / "X versus Y" / "which is bigger / better / larger / more profitable" / "rank these companies" / "head to head" — side-by-side comparison of 2–5 companies or drugs in ONE parallel call. ALWAYS PREFER over sequential single-pack lookups when comparing entities. type="company" pulls LATEST 10-K revenue + net income + cash + long-term debt from SEC EDGAR/XBRL (off-calendar fiscal years handled correctly — AAPL Sep, NVDA Jan, etc.). type="drug" pulls FAERS adverse-event counts, FDA approval counts, active trial counts. Results sorted by primary metric so "largest" / "most" / "biggest" reads off the top of the response. Returns paired data + pipeworx:// citation URIs per entity. Replaces 8–15 sequential lookups.

Input Schema

TableJSON Schema
NameRequiredDescriptionDefault
typeYesEntity type: "company" or "drug".
valuesYesFor company: 2–5 tickers/CIKs (e.g., ["AAPL","MSFT"]). For drug: 2–5 names (e.g., ["ozempic","mounjaro"]).

Schema Changelog

Changes observed during successful MCP inspections. Dates show when Glama detected each change.

  1. First observed

TDQS

A4.3/5.0
Behavior4/5

Does the description disclose side effects, auth requirements, rate limits, or destructive behavior?

Annotations already declare readOnlyHint=true and idempotentHint=true, so safety is covered. Description adds valuable behavioral context: handles off-calendar fiscal years, returns sorted results with citation URIs, and explains data sources (SEC EDGAR/XBRL for companies, FAERS/FDA for drugs).

Agents need to know what a tool does to the world before calling it. Descriptions should go beyond structured annotations to explain consequences.

Conciseness4/5

Is the description appropriately sized, front-loaded, and free of redundancy?

Description is somewhat long but every sentence adds value. It front-loads with common query patterns, then explains data handling, sorting, and output format. Could be slightly more concise but is well-structured and information-dense.

Shorter descriptions cost fewer tokens and are easier for agents to parse. Every sentence should earn its place.

Completeness4/5

Given the tool's complexity, does the description cover enough for an agent to succeed on first attempt?

Given the tool has 2 parameters and no output schema, the description adequately covers return value format (paired data with citation URIs) and sorting behavior. It also explains the data sources and special cases (fiscal year handling). Sufficient for an AI agent to invoke correctly.

Complex tools with many parameters or behaviors need more documentation. Simple tools need less. This dimension scales expectations accordingly.

Parameters4/5

Does the description clarify parameter syntax, constraints, interactions, or defaults beyond what the schema provides?

Schema coverage is 100%, baseline 3. Description adds meaning by explaining value formats (tickers/CIKs for companies, drug names) and constraints (2-5 items). Also clarifies that type='company' pulls specific financial metrics and type='drug' pulls adverse-event data.

Input schemas describe structure but not intent. Descriptions should explain non-obvious parameter relationships and valid value ranges.

Purpose5/5

Does the description clearly state what the tool does and how it differs from similar tools?

Description clearly states it performs side-by-side comparison of 2-5 companies or drugs. Provides example queries ('compare X and Y', 'which is bigger') and explicitly distinguishes from sequential single-pack lookups. Verb 'compare' and resource 'entities' are specific and well-defined.

Agents choose between tools based on descriptions. A clear purpose with a specific verb and resource helps agents select the right tool.

Usage Guidelines4/5

Does the description explain when to use this tool, when not to, or what alternatives exist?

Explicitly advises to use this tool instead of sequential lookups when comparing entities. Specifies data pulled for each type (company vs drug). Could include explicit 'do not use if' conditions, but the guidance is clear and actionable.

Agents often have multiple tools that could apply. Explicit usage guidance like "use X instead of Y when Z" prevents misuse.

Try in Browser

Glama MCP Gateway

Add one secure layer between your agents and this server.

TDQS

A3.9/5.0
Disambiguation3/5

Several tools cluster around the same core purpose: the three ask_pipeworx variants, the three census reverse-geocoders, and the six Polymarket analysis tools. Descriptions are detailed enough to disambiguate most choices, but ask_pipeworx_beta is currently identical to ask_pipeworx, creating genuine ambiguity. An agent could easily select the wrong tool in these overlapping families.

Naming Consistency3/5

Names mix verb-initial actions (ask_pipeworx, compare_entities, resolve_entity) with noun-initial compound names (census_block, entity_profile, polymarket_edges). The polymarket_* family is internally consistent, but the set as a whole lacks a uniform verb_noun convention. Single-word verbs like remember, recall, and forget further break the pattern.

Tool Count2/5

At 34 tools, this exceeds the 'too many' threshold of 25 and includes clear redundancy: ask_pipeworx_beta duplicates ask_pipeworx, county_for_point is a thin wrapper over the same service as census_area/census_block, and scan_competitor_ai_presence just loops ai_visibility_check. The broad scope does not justify this many tools, and the set would be better split into focused servers.

Completeness4/5

Each sub-domain has solid lifecycle coverage: memory has remember/recall/forget, subscriptions have subscribe/list/unsubscribe/recent_alerts, and company research has resolve_entity/entity_profile/compare_entities/recent_changes. Minor gaps exist (e.g., no direct pipeworx:// citation-fetching tool), but no critical dead ends that would cause agent failures.